Arvid Suls Selected Research

Arvid Suls Research Topics

Disease

6	Seizures (Absence Seizure) 01/2016 - 07/2008
6	Epilepsy (Aura) 11/2015 - 07/2008
5	Brain Diseases (Brain Disorder) 12/2017 - 04/2015
4	Myoclonic Epilepsies (Myoclonic Encephalopathy) 12/2015 - 09/2011
3	Dyskinesias (Dyskinesia) 07/2012 - 07/2008
2	Herpes Zoster 04/2024 - 01/2018
2	Absence Epilepsy (Childhood Absence Epilepsy) 08/2015 - 09/2009
2	Fever (Fevers) 12/2014 - 11/2013
2	Epileptic Syndromes 12/2014 - 11/2013
2	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 04/2014 - 07/2012
2	Cognitive Dysfunction 03/2014 - 11/2013
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Chronic recurrent multifocal osteomyelitis 10/2022
1	Hepatitis B 01/2022
1	Measles 01/2020
1	Rubella (German Measles) 01/2020
1	Mumps 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Bacterial Meningitis 01/2019
1	Meningitis 01/2019
1	Adenocarcinoma 01/2018
1	Autosomal Dominant 5 Deafness 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neoplasms (Cancer) 12/2017
1	Malignant Mesothelioma 12/2017
1	Infections 09/2017
1	Parkinsonian Disorders (Parkinsonism) 01/2016
1	Drug Resistant Epilepsy 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Dystonia 18 08/2015
1	Spastic Paraparesis 08/2015
1	Infantile Epileptic-Dyskinetic Encephalopathy 05/2015
1	Paraplegia (Spastic Paraplegia) 04/2015
1	Febrile Seizures (Febrile Seizure) 12/2014
1	Chorea (Rheumatic Chorea) 04/2014
1	Convulsions benign familial neonatal dominant form 03/2014
1	Infantile Spasms (West Syndrome) 01/2014
1	Partial Epilepsies (Epilepsy, Partial) 01/2014
1	Myoclonus (Nocturnal Myoclonus) 07/2012
1	Intellectual Disability (Idiocy) 12/2010
1	Idiopathic Generalized Epilepsy 01/2010

Drug/Important Bio-Agent (IBA)

5	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2015 - 07/2008
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2014
2	EpitopesIBA 04/2024 - 01/2022
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	gephyrinIBA 12/2017 - 12/2015
2	Sodium Channels (Sodium Channel)IBA 05/2015 - 04/2011
2	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 07/2008
1	Glycoproteins (Glycoprotein)IBA 04/2024
1	CytokinesIBA 10/2022
1	VaccinesIBA 01/2022
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Interferon Type IIBA 01/2019
1	InterferonsIBA 01/2019
1	HLA-A Antigens (HLA-A)IBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	AsbestosIBA 12/2017
1	RNA Polymerase IIIIBA 09/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Citric Acid (Citrate)FDA LinkGeneric 11/2015
1	Indicators and Reagents (Reagents)IBA 11/2015
1	Glucose Transporter Type 1IBA 08/2015
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2015
1	Adaptor Protein Complex 4IBA 04/2015
1	Kv1.2 Potassium ChannelIBA 04/2015
1	Syntaxin 1IBA 12/2014
1	human PRRT2 proteinIBA 04/2014
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 03/2014
1	PotassiumIBA 03/2014
1	N-Methylaspartate (NMDA)IBA 01/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014
1	Ion Channels (Ion Channel)IBA 01/2014
1	Glutamic Acid (Glutamate)FDA Link 01/2014
1	Potassium Channels (Potassium Channel)IBA 07/2012
1	Carbamazepine (Tegretol)FDA LinkGeneric 07/2012
1	Immunoglobulin E (IgE)IBA 01/2010

Therapy/Procedure

2	Therapeutics 01/2019 - 11/2013
2	Ketogenic Diet 08/2015 - 09/2009
1	Induced Hyperthermia (Thermotherapy) 12/2015